Bio-Techne
TECH
#1708
Rank
C$14.12 B
Marketcap
$89.32
Share price
0.85%
Change (1 day)
-11.54%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of December 2024 : C$3.00 Billion

According to Bio-Techne's latest financial reports the company has C$3.00 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$C$2.60 B18.9%
2022-06-30$C$2.19 B12.51%
2021-06-30$C$1.94 B3.26%
2020-06-30$C$1.88 B23.29%
2019-06-30$C$1.52 B7.82%
2018-06-30$C$1.41 B15%
2017-06-30$C$1.23 B8.49%
2016-06-30$C$1.13 B8.19%
2015-06-30$C$1.05 B23.94%
2014-06-30$C$0.84 B9.32%
2013-06-30$C$0.77 B12.98%
2012-06-30$C$0.68 B21.11%
2011-06-30$C$0.56 B6.34%
2010-06-30$C$0.53 B0.51%
2009-06-30$C$0.53 B6.84%
2008-06-30$C$0.49 B7.03%
2007-06-30$C$0.46 B22.28%
2006-06-30$C$0.37 B15.65%
2005-06-30$C$0.32 B-17.27%
2004-06-30$C$0.39 B24.42%
2003-06-30$C$0.31 B1.81%
2002-06-30$C$0.31 B16.31%
2001-06-30$C$0.26 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$71.85 B 2,289.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.50 B 216.06%๐Ÿ‡บ๐Ÿ‡ธ USA
C$36.45 B 1,112.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$71.67 B 2,283.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.10 B 69.83%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$28.30 B 841.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$68.93 M-97.71%๐Ÿ‡บ๐Ÿ‡ธ USA